Coherus Oncology, Inc. (CHRS) Stock Price History
Historical prices from 2014 to 2026
- 1M
- +17.6%
- 3M
- +0.0%
- YTD
- +21.9%
- 1Y
- +123.8%
- 3Y
- -29.9%
- 5Y
- -34.1%
Loading 10-year price history...
CHRS Historical Performance
CHRS Annual Returns
Year-by-year price performance · 2014–2026
- 2014 annual price return
- +29.4%
- 2015 annual price return
- +45.1%
- 2016 annual price return
- +33.6%
- 2017 annual price return
- -68.6%
- 2018 annual price return
- -5.2%
- 2019 annual price return
- +97.4%
- 2020 annual price return
- -5.1%
- 2021 annual price return
- -5.6%
- 2022 annual price return
- -51.7%
- 2023 annual price return
- -60.9%
- 2024 annual price return
- -56.1%
- 2025 annual price return
- +1.4%
- 2026 annual price return
- +21.9%
CHRS Stock Price Trajectory (2014–2026)
As of July 8, 2026, Coherus Oncology, Inc. (CHRS) trades at $1.67, representing a +123.8% return over the past year. The stock has delivered a -87.5% total return over five years (-34.1% CAGR), reflecting challenging market conditions.
The stock reached its all-time high of $38.10 on July 22, 2015. From this peak, CHRS has corrected -95.6%, currently trading 3% above its 200-day moving average, indicating continued institutional support.
When compared to Healthcare sector peers PRGO (-58.2% 1Y), AMRX (+102.7% 1Y), and HCM (-28.1% 1Y), CHRS has underperformed the peer group average. Compare CHRS vs PRGO →
CHRS Historical Price Data · from 2014
Rows 1–50 of 2,932| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-07-07 | 1.56 | 1.71 | 1.53 | 1.67 | 1.52M | +7.05% |
| 2026-07-06 | 1.46 | 1.59 | 1.43 | 1.56 | 1.53M | +7.59% |
| 2026-07-02 | 1.44 | 1.49 | 1.42 | 1.45 | 846K | +0.69% |
| 2026-07-01 | 1.40 | 1.49 | 1.40 | 1.44 | 585K | +2.86% |
| 2026-06-30 | 1.44 | 1.46 | 1.40 | 1.40 | 654K | -3.45% |
| 2026-06-29 | 1.52 | 1.52 | 1.44 | 1.45 | 1.03M | -3.33% |
| 2026-06-26 | 1.48 | 1.52 | 1.46 | 1.50 | 0 | +1.35% |
| 2026-06-25 | 1.52 | 1.56 | 1.48 | 1.48 | 497K | -2.63% |
| 2026-06-24 | 1.49 | 1.55 | 1.48 | 1.52 | 777K | +4.11% |
| 2026-06-23 | 1.44 | 1.52 | 1.44 | 1.46 | 496K | -1.35% |
| 2026-06-22 | 1.45 | 1.56 | 1.43 | 1.48 | 905K | 0.00% |
| 2026-06-18 | 1.44 | 1.49 | 1.39 | 1.48 | 1.26M | +6.47% |
| 2026-06-17 | 1.38 | 1.42 | 1.36 | 1.39 | 638K | +1.46% |
| 2026-06-16 | 1.37 | 1.39 | 1.33 | 1.37 | 1.11M | +0.74% |
| 2026-06-15 | 1.43 | 1.45 | 1.36 | 1.36 | 708K | -2.86% |
| 2026-06-12 | 1.42 | 1.45 | 1.39 | 1.40 | 504K | -1.41% |
| 2026-06-11 | 1.36 | 1.44 | 1.33 | 1.42 | 783K | +4.41% |
| 2026-06-10 | 1.43 | 1.45 | 1.35 | 1.36 | 644K | -4.23% |
| 2026-06-09 | 1.44 | 1.49 | 1.42 | 1.42 | 683K | 0.00% |
| 2026-06-08 | 1.47 | 1.49 | 1.42 | 1.42 | 622K | -2.07% |
| 2026-06-05 | 1.54 | 1.54 | 1.44 | 1.45 | 897K | -7.94% |
| 2026-06-04 | 1.50 | 1.59 | 1.50 | 1.57 | 832K | +7.14% |
| 2026-06-03 | 1.52 | 1.52 | 1.46 | 1.47 | 1.02M | -3.29% |
| 2026-06-02 | 1.55 | 1.56 | 1.51 | 1.52 | 891K | -3.18% |
| 2026-06-01 | 1.61 | 1.64 | 1.56 | 1.57 | 807K | -1.26% |
| 2026-05-29 | 1.66 | 1.68 | 1.58 | 1.59 | 1.53M | -3.64% |
| 2026-05-28 | 1.65 | 1.67 | 1.64 | 1.65 | 481K | -0.60% |
| 2026-05-27 | 1.66 | 1.74 | 1.64 | 1.66 | 1.19M | +1.22% |
| 2026-05-26 | 1.65 | 1.72 | 1.63 | 1.64 | 1.17M | +1.86% |
| 2026-05-22 | 1.60 | 1.65 | 1.59 | 1.61 | 911K | +2.55% |
| 2026-05-21 | 1.51 | 1.60 | 1.48 | 1.57 | 1.38M | +3.97% |
| 2026-05-20 | 1.47 | 1.56 | 1.47 | 1.51 | 699K | +2.03% |
| 2026-05-19 | 1.48 | 1.50 | 1.46 | 1.48 | 1.37M | -0.67% |
| 2026-05-18 | 1.60 | 1.60 | 1.46 | 1.49 | 1.77M | -5.10% |
| 2026-05-15 | 1.61 | 1.65 | 1.56 | 1.57 | 1.50M | -3.68% |
| 2026-05-14 | 1.70 | 1.73 | 1.63 | 1.63 | 1.98M | -4.40% |
| 2026-05-13 | 1.71 | 1.79 | 1.60 | 1.71 | 2.40M | -0.29% |
| 2026-05-12 | 1.75 | 1.82 | 1.62 | 1.71 | 3.46M | -12.31% |
| 2026-05-11 | 1.90 | 2.10 | 1.88 | 1.95 | 3.66M | +11.43% |
| 2026-05-08 | 1.77 | 1.80 | 1.74 | 1.75 | 660K | -0.57% |
| 2026-05-07 | 1.73 | 1.76 | 1.71 | 1.76 | 903K | +0.57% |
| 2026-05-06 | 1.83 | 1.87 | 1.75 | 1.75 | 1.28M | -2.23% |
| 2026-05-05 | 1.74 | 1.80 | 1.74 | 1.79 | 803K | +3.47% |
| 2026-05-04 | 1.81 | 1.82 | 1.73 | 1.73 | 715K | -3.89% |
| 2026-05-01 | 1.75 | 1.80 | 1.73 | 1.80 | 516K | +1.41% |
| 2026-04-30 | 1.75 | 1.83 | 1.74 | 1.77 | 437K | +2.01% |
| 2026-04-29 | 1.75 | 1.75 | 1.70 | 1.74 | 656K | -1.69% |
| 2026-04-28 | 1.79 | 1.85 | 1.75 | 1.77 | 624K | -3.80% |
| 2026-04-27 | 1.75 | 1.89 | 1.74 | 1.84 | 1.03M | +5.14% |
| 2026-04-24 | 1.76 | 1.76 | 1.72 | 1.75 | 906K | -0.57% |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
10-year return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
CHRS — Frequently Asked Questions
Quick answers to the most common questions about buying CHRS stock.
How has CHRS stock performed recently?
CHRS returned +123.8% over the past year, beating its 5-year annualized CAGR of -34.1%. The stock trades above its 200-day moving average, confirming the uptrend.
What is CHRS's all-time high price?
Coherus Oncology, Inc. reached $38.10 on 2015-07-22. The 52-week high is $2.62. Current 1-year return of +123.8% places the stock closer to historical peaks.
Where can I download CHRS historical price data?
This page provides CHRS daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2014-2026, downloadable in CSV format.